Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Blueprint Medicines Corp | Director | Common Stock | 18.3K | $1.92M | $105.13 | Jun 12, 2024 | Direct |
GLYCOMIMETICS INC | Director | Common Stock | 24.8K | $74.5K | $3.00 | Mar 29, 2024 | Direct |
GLYCOMIMETICS INC | Director | Common Stock | 11.5K | $34.5K | $3.00 | Mar 29, 2024 | By family trusts |
ImmunoGen, Inc. | Director | Common Stock | 0 | $0 | $29.30 | Feb 12, 2024 | Direct |
ImmunoGen, Inc. | Director | Deferred Share Unit | 0 | $0 | $29.30 | Feb 12, 2024 | Direct |
ImmunoGen, Inc. | Director | Restricted Stock Unit | 0 | $0 | $29.30 | Feb 12, 2024 | Direct |
GLYCOMIMETICS INC | Director | Stock Option (right to buy) | 40K | May 1, 2024 | Direct | ||
IDERA PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 26K | Jun 23, 2022 | Direct | ||
Blueprint Medicines Corp | Director | Stock Option (Right to Buy) | 4.57K | Jun 12, 2024 | Direct | ||
ImmunoGen, Inc. | Director | Stock Option (Right to Buy) | 0 | $4.56 | Feb 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BPMC | Blueprint Medicines Corp | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
GLYC | GLYCOMIMETICS INC | May 1, 2024 | 1 | $0 | 4 | May 1, 2024 | Director |
GLYC | GLYCOMIMETICS INC | Mar 29, 2024 | 1 | $13.8K | 4 | Apr 2, 2024 | Director |
IMGN | ImmunoGen, Inc. | Feb 12, 2024 | 13 | $0 | 4 | Feb 12, 2024 | Director |
IMGN | ImmunoGen, Inc. | Dec 29, 2023 | 1 | $16.9K | 4 | Jan 3, 2024 | Director |
GLYC | GLYCOMIMETICS INC | Dec 29, 2023 | 1 | $13.8K | 4 | Jan 2, 2024 | Director |
IMGN | ImmunoGen, Inc. | Oct 30, 2023 | 3 | -$3.8K | 4 | Nov 1, 2023 | Director |
GLYC | GLYCOMIMETICS INC | Sep 30, 2023 | 1 | $13.8K | 4 | Oct 3, 2023 | Director |
IMGN | ImmunoGen, Inc. | Sep 29, 2023 | 1 | $16.9K | 4 | Oct 2, 2023 | Director |
IMGN | ImmunoGen, Inc. | Jun 30, 2023 | 1 | $16.9K | 4 | Jul 5, 2023 | Director |
BPMC | Blueprint Medicines Corp | Jun 21, 2023 | 2 | $0 | 4 | Jun 23, 2023 | Director |
IMGN | ImmunoGen, Inc. | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
GLYC | GLYCOMIMETICS INC | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
IMGN | ImmunoGen, Inc. | Mar 31, 2023 | 1 | $16.9K | 4 | Apr 4, 2023 | Director |
IMGN | ImmunoGen, Inc. | Dec 30, 2022 | 1 | $0 | 4 | Jan 4, 2023 | Director |
IMGN | ImmunoGen, Inc. | Sep 30, 2022 | 1 | $0 | 4 | Oct 4, 2022 | Director |
IMGN | ImmunoGen, Inc. | Jun 30, 2022 | 1 | $0 | 4 | Jul 5, 2022 | Director |
IDRA | IDERA PHARMACEUTICALS, INC. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
BPMC | Blueprint Medicines Corp | Jun 21, 2022 | 2 | $0 | 4 | Jun 30, 2022 | Director |
IMGN | ImmunoGen, Inc. | Jun 15, 2022 | 2 | $148K | 4 | Jun 17, 2022 | Director |
GLYC | GLYCOMIMETICS INC | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
IMGN | ImmunoGen, Inc. | Mar 31, 2022 | 1 | $0 | 4/A | Apr 20, 2022 | Director |
BPMC | Blueprint Medicines Corp | Mar 3, 2022 | 1 | $300K | 4 | Mar 7, 2022 | Director |
IMGN | ImmunoGen, Inc. | Dec 31, 2021 | 1 | $0 | 4 | Jan 4, 2022 | Director |
IMGN | ImmunoGen, Inc. | Sep 30, 2021 | 1 | $0 | 4 | Oct 1, 2021 | Director |
IMGN | ImmunoGen, Inc. | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
IMGN | ImmunoGen, Inc. | Jun 16, 2021 | 2 | $298K | 4 | Jun 17, 2021 | Director |
IDRA | IDERA PHARMACEUTICALS, INC. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
BPMC | Blueprint Medicines Corp | Jun 2, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
GLYC | GLYCOMIMETICS INC | May 18, 2021 | 2 | $0 | 4 | May 27, 2021 | Director |